US Stock MarketDetailed Quotes

LXEO Lexeo Therapeutics

Watchlist
  • 17.380
  • -1.380-7.36%
Close Jun 14 16:00 ET
  • 17.380
  • 0.0000.00%
Post 16:05 ET
572.59MMarket Cap-8244P/E (TTM)

Lexeo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lexeo Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.77

-3.88%
Analyst Rating

Strong Buy

Jun 12, 2024

Lexeo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Lexeo Therapeutics Earnings Reports

  • Lexeo Therapeutics | 10-Q: Quarterly report

    May 9 07:07 ET

  • Lexeo Therapeutics | 10-K: Annual report

    Mar 11 09:31 ET

  • Lexeo Therapeutics | 10-Q: Quarterly report

    Dec 11, 2023 07:02 ET

    • Analysis

    Analyst Rating

    Updated: Jun 12, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg